Cover Image

Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women

Introduction. Coronavirus infection is associated with severe endotheliopathy, thromboinflammation and immunothrombosis leading to excessive release of von Willebrand factor (vWF) multimers from Weibel-Palade bodies, which can affect activity of ADAMTS-13 metalloproteinase (a disintegrin and metallo...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. R. Gashimova (Author), K. N. Grigoreva (Author), V. O. Bitsadze (Author), L. L. Pankratyeva (Author), J. Kh. Khizroeva (Author), M. V. Tretyakova (Author), Ya. M. Shammut (Author), E. Iu. Iupatov (Author), V. I. Tsibizova (Author), J.-K. Gris (Author), D. V. Blinov (Author), A. D. Makatsariya (Author)
Format:	Book
Published:	IRBIS LLC, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
by: E. V. Slukhanchuk, et al.
Published: (2023)

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023)

Comparative assessment of changes ADAMTS-13/von Willebrand factor axis in singleton and bichorial biamniotic pregnancy
by: F. Е. Yagubova, et al.
Published: (2024)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022)

Intrauterine activation of the fetal immune system in response to maternal COVID-19
by: N. R. Gashimova, et al.
Published: (2023)

Dysregulated platelet function in COVID-19 patients
by: N. R. Gashimova, et al.
Published: (2023)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022)

Metalloproteinases as biochemical markers of pregnancy pathology
by: K. N. Grigorieva, et al.
Published: (2022)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
by: Emma Birnie, et al.
Published: (2017)

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
by: Emma Birnie, et al.
Published: (2020)

How to reduce a risk of venous thromboembolism while taking combined oral contraceptives
by: V. O. Bitsadze, et al.
Published: (2023)

Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13.
by: Kis Djamiatun, et al.
Published: (2012)

Pregnancy and Zika virus
by: T. V. Startseva, et al.
Published: (2020)

Neonatal thrombosis: risk factors and principles of prophylaxis
by: A. V. Vorobev, et al.
Published: (2021)

Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology
by: A. D. Makatsariya, et al.
Published: (2021)

Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014-2018
by: A. D. Makatsariya, et al.
Published: (2019)

Septic shock
by: V. O. Bitsadze, et al.
Published: (2020)

Antithrombotic therapy in COVID-19 patients
by: E. V. Slukhanchuk, et al.
Published: (2023)

Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
by: A. D. Makatsariya, et al.
Published: (2020)

Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers
by: J. H. Khizroeva, et al.
Published: (2020)

Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021)

Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022)

To a question about the necessity and indications for genetic screening in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2023)

Management of antithrombin III deficiency in pregnancy: a representative case and a literature review
by: S. V. Akinshina, et al.
Published: (2021)

The concept of thromboinflammation underlying thrombotic complications, tumor progression and metastasis in gynecological cancer patients
by: A. D. Makatsariya, et al.
Published: (2024)

Features of nervous system damage in antiphospholipid syndrome
by: O. N. Voskresenskaya, et al.
Published: (2021)

Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19
by: A. D. Makatsariya, et al.
Published: (2021)

Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis
by: Elvira Grandone, et al.
Published: (2022)

Macrophage activation syndrome in COVID-19
by: K. N. Grigorieva, et al.
Published: (2021)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021)

Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis
by: A. D. Makatsariya, et al.
Published: (2024)

HELLP-SYNDROME
by: A. D. Makatsariya, et al.
Published: (2016)

Multiple pregnancy in fine arts
by: N. A. Makatsariya, et al.
Published: (2023)

The role of platelets in antiviral immunity
by: E. V. Slukhanchuk, et al.
Published: (2022)